Literature DB >> 31141401

Accumulation of uremic solutes in the cerebrospinal fluid in experimental acute renal failure.

Robert DeWolfe Mair1,2, Huy Nguyen3, Ting-Ting Huang3,4, Natalie S Plummer2, Tammy L Sirich1,2, Timothy W Meyer1,2.   

Abstract

The accumulation of uremic solutes in kidney failure may impair mental function. The present study profiled the accumulation of uremic solutes in the cerebrospinal fluid (CSF) in acute renal failure. CSF and plasma ultrafiltrate were obtained from rats at 48 h after sham operation (control; n = 10) or bilateral nephrectomy (n = 10) and analyzed using an established metabolomic platform. Two hundred forty-eight solutes were identified as uremic based on their accumulation in the plasma ultrafiltrate of nephrectomized compared with control rats. CSF levels of 124 of these solutes were sufficient to allow calculation of CSF-to-plasma ultrafiltrate concentration ratios. Levels of many of the uremic solutes were normally lower in the CSF than in the plasma ultrafiltrate, indicating exclusion of these solutes from the brain. CSF levels of the great majority of the uremic solutes increased in renal failure. The increase in the CSF was, however, relatively less than in the plasma ultrafiltrate for most solutes. In particular, for the 31 uremic solutes with CSF-to-plasma ultrafiltrate ratios of <0.25 in control rats, the average CSF-to-plasma ultrafiltrate ratio decreased from 0.13 ± 0.07 in control rats to 0.09 ± 0.06 in nephrectomized rats, revealing sustained ability to exclude these solutes from the brain. In summary, levels of many uremic solutes are normally kept lower in the CSF than in the plasma ultrafiltrate by the action of the blood-brain and blood-CSF barriers. These barriers remain functional but cannot prevent accumulation of uremic solutes in the CSF when the kidneys fail.

Entities:  

Keywords:  brain; cerebrospinal fluid; end-stage renal disease; uremic encephalopathy; uremic toxins

Mesh:

Substances:

Year:  2019        PMID: 31141401      PMCID: PMC6732458          DOI: 10.1152/ajprenal.00100.2019

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  42 in total

Review 1.  Neurologic disorders in renal failure (first of two parts).

Authors:  N H Raskin; R A Fishman
Journal:  N Engl J Med       Date:  1976-01-15       Impact factor: 91.245

2.  Secretory activity and aryl acid content of serum, urine, and cerebrospinal fluid in normal and uremic man.

Authors:  R D Porter; W F Cathcart-Rake; S H Wan; F C Whittier; J J Grantham
Journal:  J Lab Clin Med       Date:  1975-05

3.  Empirical bayes methods and false discovery rates for microarrays.

Authors:  Bradley Efron; Robert Tibshirani
Journal:  Genet Epidemiol       Date:  2002-06       Impact factor: 2.135

4.  Ventricular choline transport: a role for organic cation transporter 2 expressed in choroid plexus.

Authors:  D H Sweet; D S Miller; J B Pritchard
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

Review 5.  Neurological complications in renal failure: a review.

Authors:  R Brouns; P P De Deyn
Journal:  Clin Neurol Neurosurg       Date:  2004-12       Impact factor: 1.876

6.  Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier.

Authors:  Tsuneo Deguchi; Kouya Isozaki; Kouno Yousuke; Tetsuya Terasaki; Masaki Otagiri
Journal:  J Neurochem       Date:  2006-02       Impact factor: 5.372

7.  Brain uptake of myoinositol after exogenous administration.

Authors:  Stephen M Silver; Barbara M Schroeder; Richard H Sterns
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

8.  Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 (Slc22a8)-null mice.

Authors:  Destiny Sykes; Douglas H Sweet; Simon Lowes; Sanjay K Nigam; John B Pritchard; David S Miller
Journal:  Am J Physiol Renal Physiol       Date:  2003-12-23

9.  The effect of uremia on penicillin flux between blood and cerebrospinal fluid.

Authors:  R Spector; S R Snodgrass
Journal:  J Lab Clin Med       Date:  1976-05

10.  Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain.

Authors:  Sumio Ohtsuki; Hiroshi Asaba; Hitomi Takanaga; Tsuneo Deguchi; Ken-ichi Hosoya; Masaki Otagiri; Tetsuya Terasaki
Journal:  J Neurochem       Date:  2002-10       Impact factor: 5.372

View more
  3 in total

Review 1.  Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?

Authors:  Sophie Liabeuf; Marion Pepin; Casper F M Franssen; Davide Viggiano; Sol Carriazo; Ron T Gansevoort; Loreto Gesualdo; Gaye Hafez; Jolanta Malyszko; Christopher Mayer; Dorothea Nitsch; Alberto Ortiz; Vesna Pešić; Andrzej Wiecek; Ziad A Massy
Journal:  Nephrol Dial Transplant       Date:  2021-12-28       Impact factor: 5.992

Review 2.  Acute Kidney Injury and Organ Dysfunction: What Is the Role of Uremic Toxins?

Authors:  Jesús Iván Lara-Prado; Fabiola Pazos-Pérez; Carlos Enrique Méndez-Landa; Dulce Paola Grajales-García; José Alfredo Feria-Ramírez; Juan José Salazar-González; Mario Cruz-Romero; Alejandro Treviño-Becerra
Journal:  Toxins (Basel)       Date:  2021-08-09       Impact factor: 4.546

Review 3.  Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight.

Authors:  Chia-Ter Chao; Shih-Hua Lin
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.